| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/11/2003 | US6531502 3-Methylidenyl-2-indolinone modulators of protein kinase |
| 03/11/2003 | US6531494 Gem-substituted αvβ3 antagonists |
| 03/11/2003 | US6531487 Water solubility; bioavailability |
| 03/11/2003 | US6531477 Treating cancer or other proliferative diseases |
| 03/11/2003 | US6531475 Corticotropin-releasing factor receptor antagonists |
| 03/11/2003 | US6531468 Inhibiting serotonin reuptake in the central nervous system of a mammal |
| 03/11/2003 | US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites |
| 03/11/2003 | CA2121230C 1,3-dihydro-2h-imidazo(4,5-b) quinolin-2-one derivatives |
| 03/06/2003 | WO2003018582A1 Novel imidazopyridine compounds with therapeutic effect |
| 03/06/2003 | WO2003018581A1 1,2-dihydro-2-oxo-1,8-naphthyridine derivative |
| 03/06/2003 | WO2003018580A1 Naphthyridine derivative |
| 03/06/2003 | WO2003018579A1 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 03/06/2003 | WO2003018548A2 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof |
| 03/06/2003 | WO2003018546A2 Tricyclic pyridin-2-one analogues as ligands for gaba-a receptors |
| 03/06/2003 | WO2003018021A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents |
| 03/06/2003 | WO2003017927A2 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 03/06/2003 | WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/06/2003 | WO2002094830A3 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS |
| 03/06/2003 | WO2002089780A3 Antiviral compounds |
| 03/06/2003 | US20030045567 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 03/06/2003 | US20030045546 Anticancer agents |
| 03/06/2003 | US20030045544 Bactericides for the oral region of animals using 3-carboxy-4-oxo quinoline or 1,8-naphthyridine derivatives or 1-cyclopropyl-3-carboyx-4-oxo quinolizine derivatives |
| 03/06/2003 | US20030045543 Systems and methods for treating a mucosal surface |
| 03/06/2003 | US20030045540 Nicotinic acetylcholine receptors antagonists; central nervous system disorder treatments |
| 03/06/2003 | US20030045538 Viologen linked acridine based molecule and process for the preparation thereof |
| 03/06/2003 | US20030045535 Antiproliferative and antitumor agents |
| 03/06/2003 | US20030045525 Particularly in the treatment of benign prostatic hyperplasia. |
| 03/06/2003 | US20030045520 Tricyclic compound having spiro union |
| 03/06/2003 | US20030045516 Chemokine receptor antagonists and methods of use therefor |
| 03/06/2003 | US20030044399 Method of treatment |
| 03/06/2003 | CA2458217A1 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 03/06/2003 | CA2457838A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents |
| 03/06/2003 | CA2456350A1 Novel imidazopyridine compounds with therapeutic effect |
| 03/06/2003 | CA2456349A1 1,2-dihydro-2-oxo-1,8-naphthyridine derivative |
| 03/05/2003 | EP1288216A1 Tricyclic quinazolinediones |
| 03/05/2003 | EP1288205A1 Novel phenylalanine derivatives |
| 03/05/2003 | EP1287532A2 Method for producing ?18 f]fluoride ion |
| 03/05/2003 | EP1287004A1 Synthetic process for the manufacture of an ecteinascidin compound |
| 03/05/2003 | EP1286999A1 PYRANO[2,3-c]IMIDAZO[1,2-a]PYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS |
| 03/05/2003 | EP1286995A1 2,7-naphthyridine derivatives |
| 03/05/2003 | EP1286994A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 03/05/2003 | EP1286993A1 Imidazopyridin-8-ones |
| 03/05/2003 | EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1286673A2 Ligands of integrin receptors |
| 03/05/2003 | EP1183255B1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 03/05/2003 | EP1054859A4 Processes and intermediates useful to make antifolates |
| 03/05/2003 | EP0801067B1 Novel quinuclidine derivatives and medicinal composition thereof |
| 03/05/2003 | EP0627433B1 Process for producing imidazopyridine derivative and intermediate |
| 03/05/2003 | CN1400974A Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors |
| 03/05/2003 | CN1400969A Fused imidazolium derivatives |
| 03/05/2003 | CN1400505A Image forming material and ammonium compound |
| 03/05/2003 | CN1102583C Cationic polypeptide condensing agent of thiazole,its synthesizing process and its application |
| 03/04/2003 | US6528649 Imidazoloisoquinolines |
| 03/04/2003 | US6528534 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 03/04/2003 | US6528526 Inhibition of cell proliferation and/or cell matrix production and/or cell movement (chemotaxis) and/or T cell activation and proliferation |
| 03/04/2003 | US6528509 Pyrazole compositions useful as inhibitors of ERK |
| 02/27/2003 | WO2003016563A2 Novel molecular target for neurotoxicity |
| 02/27/2003 | WO2003016318A1 Tumour inhibiting lanthane compounds |
| 02/27/2003 | WO2003016316A1 Diazacycloalkanes as oxytocin agonists |
| 02/27/2003 | WO2003016315A1 Sodium salt of an hiv integrase inhibitor |
| 02/27/2003 | WO2003016311A1 Tricyclic pyridin-2-one analogues as ligands for gaba-a receptors |
| 02/27/2003 | WO2003016310A1 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| 02/27/2003 | WO2003016309A1 Process for preparing 5-sulfonamido-8-hydroxy-1, 6-naphthyridine-7-carboxamides |
| 02/27/2003 | WO2003016279A1 Fused-polycyclic compounds |
| 02/27/2003 | WO2003016248A2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
| 02/27/2003 | WO2003015785A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/27/2003 | WO2003015773A2 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases |
| 02/27/2003 | WO2003015517A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
| 02/27/2003 | WO2002100862A3 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 02/27/2003 | WO2002100851A3 Thiophene derivatives as antiviral agents for flavivirus infection |
| 02/27/2003 | WO2002090325A3 Benzazepinone alpha v integrin receptor antagonists |
| 02/27/2003 | WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof |
| 02/27/2003 | WO2002085903A3 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 02/27/2003 | WO2002085301A3 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 02/27/2003 | WO2002064590A3 Carboline derivatives |
| 02/27/2003 | WO2002046193A3 Heterocyclic ether substituted imidazoquinolines |
| 02/27/2003 | WO2002040477A3 Saframycins, analogues and uses thereof |
| 02/27/2003 | WO2002028865A3 Condensed pyridoindole derivatives |
| 02/27/2003 | US20030040639 Reacting polymer bound chemical intermediate compound with complex to produce complex compound; reacting with nucleophile(s); benzene derivative is decomplexed, optionally derivatised, cleaved from the support |
| 02/27/2003 | US20030040536 For therapy of disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease |
| 02/27/2003 | US20030040533 For use as hypoglycaemic and hypolipidaemic agents |
| 02/27/2003 | US20030040527 Having anti-mitotic activity for therapy of cancer |
| 02/27/2003 | US20030040525 Inhibition of human telomerase by a G-quadruplex-interaction compound |
| 02/27/2003 | US20030040521 For controlling and preventing pests |
| 02/27/2003 | US20030040518 For therapy of neurodegenerative diseases and for the regeneration or prevention of degeneration of lesioned and damaged neurons degeneration of lesioned and damaged neurons |
| 02/27/2003 | CA2457611A1 Novel molecular target for neurotoxicity |
| 02/27/2003 | CA2456985A1 2h-phthalazin-1-ones and methods for use thereof |
| 02/27/2003 | CA2456551A1 Tumour inhibiting lanthanum compounds |
| 02/27/2003 | CA2456290A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
| 02/27/2003 | CA2456206A1 Sodium salt of an hiv integrase inhibitor |
| 02/27/2003 | CA2456155A1 Process for preparing 5-sulfonamido-8-hydroxy-1, 6-naphthyridine-7-carboxamides |
| 02/27/2003 | CA2453962A1 Diazacycloalkanes as oxytocin agonists |
| 02/27/2003 | CA2452801A1 Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| 02/26/2003 | EP1285921A1 A process for the preparation of high purity pemirolast |
| 02/26/2003 | EP1285651A1 Melanin concentrating hormone antagonists |
| 02/26/2003 | EP1284976A2 Diazabicyclic central nervous system active agents |
| 02/26/2003 | EP1284732A2 Method for treating functional dyspepsia using alosetron |
| 02/26/2003 | EP1100797B1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/26/2003 | EP1042324B1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof |
| 02/26/2003 | CN1399537A Composition for dyeing keratnous fibres containing 3-amino pyrazolo-[1,5-A]-pyridines, dyeing method, novel 3-amino pyrazolo-[1,5-A]-pyridines |